2 Einträge |
Seite 1 / 1
![]() |
Early clinical outcomes as a function of use of newer oral P2Y12 inhibitors versus clopidogrel in the EUROMAX trial. |
Huber K, Ducrocq G, Hamm CW, van 't Hof A, Lapostolle F, Coste P, Gordini G, Steinmetz J, Verheugt FWA, Adgey J, Nibbe L, Kaniĉ V, Clemmensen P, Zeymer U, Bernstein D, Prats J, Deliargyris EN, Gabriel Steg P |
Open heart. 2017 Nov 28. doi: 10.1136/openhrt-2017-000677. pii: openhrt-2017-000677. pmc: PMC5708315 |
PMID: 29225903 |
Balance of Benefit and Risk of Ticagrelor in Patients With Diabetes and Stable Coronary Artery Disease According to Bleeding Risk Assessment With the CRUSADE Score: Data From THEMIS and THEMIS PCI: Abbreviated title: Bleeding risk stratification of ticagrelor. |
Ducrocq G, Bhatt DL, Lee JJ, Kui N, Fox KM, Harrington RA, Leiter LA, Mehta SR, Kiss RG, James S, Vinereanu D, Huber K, Andersson M, Himmelmann A, Simon T, Gabriel Steg P |
American heart journal. 2022 Mar 20. pii: S0002-8703(22)00055-2. doi: 10.1016/j.ahj.2022.03.008 |
PMID: 35321823 |
2 Einträge |
Seite 1 / 1
![]() |